4'-Trifluoromethylbiphenyl-2-carbaldehyde, 95.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 50 µl, 1705 RNR, 1 piece

(1R,2R)-N1,N1-Dibenzylcyclohexane-1,2-diamine, 97%, 100mg

6-Bromoquinolin-5-amine, 97%, 1g

(3,5,6-Trimethylpyrazin-2-yl)methanol, 95.0%, 10g

6-CHLORO-3-METHYL-4-QUINAZOLINONE, 97.0%, 250mg

2-(2-Aminoethoxy)-4-chloropyridine, 95+%, 250mg

3,5,5-Trimethylhexyl Acetate>93.0%(GC)25mL

2-Isopropyl-5-methyl-2H-pyrazol-3-ylamine, 95.0%, 10g

5-Cyclobutyl-5-oxovaleric acid, 97.0%, 1g

3,4-Diiodopyridine, 97%, 100mg

6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile trihydrochloride, 98%, 1g

2-Hydroxy-N-(5-nitro-2-thiazolyl)-benzamide, 90.0%, 5g